MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-07-2024
Lumos Pharma Cash Conversion Cycle 2011-2026 | LUMO
Quarterly Cash Conversion Cycle Lumos Pharma
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 42.4 | 565 | 142 | 54 | 224 | 96.5 | 64.2 | 34.6 | 66 | 10.6 | 2 | 121 | 1.6 K | 689 | 412 | 457 | 522 | 230 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.6 K | 2 | 296 |
Cash Conversion Cycle of other stocks in the Biotechnology industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Advaxis
ADXS
|
-143 K | - | -9.65 % | $ 45.9 M |  USA |
 |
Compugen Ltd.
CGEN
|
-82.7 | $ 2.65 | -2.93 % | $ 248 M |  Israel |
 |
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M |  China |
 |
Ampio Pharmaceuticals
AMPE
|
-2.85 K | - | -11.43 % | $ 502 K | USA |
 |
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | USA |
 |
Aptorum Group Limited
APM
|
-400 | $ 0.88 | - | $ 6.47 M | China |
 |
ACADIA Pharmaceuticals
ACAD
|
257 | $ 22.5 | -0.75 % | $ 3.73 B | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | USA |
 |
AIkido Pharma
AIKI
|
-1.92 | - | 1.93 % | $ 17.4 M | USA |
 |
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | USA |
 |
Galapagos NV
GLPG
|
67.1 | $ 27.55 | -3.08 % | $ 2.69 B |  Belgium |
 |
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - |  Russia |
 |
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M |  Canada |
 |
Ayala Pharmaceuticals
AYLA
|
-2.15 K | - | - | $ 7.46 M | Israel |
 |
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | USA |
 |
Aridis Pharmaceuticals
ARDS
|
59 | - | 17.91 % | $ 11.1 M | USA |
 |
BioDelivery Sciences International
BDSI
|
340 | - | -4.8 % | $ 255 M | USA |
 |
Innoviva
INVA
|
24.6 | $ 23.23 | -1.94 % | $ 1.57 B | USA |
 |
Aquestive Therapeutics
AQST
|
-172 | $ 4.07 | -0.61 % | $ 435 M | USA |
 |
Jaguar Health
JAGX
|
289 | $ 0.23 | -5.27 % | $ 536 K | USA |
 |
Arcutis Biotherapeutics
ARQT
|
158 | $ 22.56 | -3.13 % | $ 2.87 B | USA |
 |
KalVista Pharmaceuticals
KALV
|
-816 | $ 26.71 | 38.8 % | $ 1.44 B | Britain |
 |
Autolus Therapeutics plc
AUTL
|
119 | $ 1.4 | -5.74 % | $ 373 M | Britain |
 |
Kamada Ltd.
KMDA
|
163 | $ 8.15 | - | $ 260 M | Israel |
 |
AstraZeneca PLC
AZN
|
-58 | - | - | $ 96.9 B | Britain |
 |
BeiGene, Ltd.
BGNE
|
52.6 | - | 0.49 % | $ 251 B |  Cayman-islands |